PharMerica Corp is a listed company. Filings by its managers are published through SEC (Form 4). PharMerica Corp has had no insider filing for more than a year; the last one goes back to 11 December 2017.
Over the whole record (from 2016), the tally stands at no purchases and 2 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2016 · cache
25 of 108 declarations
PharMerica Corp is a company specializing in pharmaceutical services management, providing solutions to healthcare facilities. It primarily operates in the United States.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2016 | 2.09 bn USD | 21.6 m USD | 0.69 USD | 10-K |
| Dec 2015 | 2.03 bn USD | 35.1 m USD | 1.14 USD | 10-K |
| Dec 2014 | 1.89 bn USD | 6.8 m USD | 0.22 USD | 10-K |
| Dec 2013 | 1.76 bn USD | 18.9 m USD | 0.63 USD | 10-K |
| Dec 2012 | 1.83 bn USD | 22.9 m USD | 0.77 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.